Sistilli Carlo 4
4 · Edesa Biotech, Inc. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
Sistilli Carlo
Director
Transactions
- Award
Common Shares
2025-05-29+20,001→ 30,417 total
Holdings
- 522(indirect: Held by York-Cav Enterprises, Inc.)
Common Shares
Footnotes (2)
- [F1]Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date.
- [F2]York-Cav Enterprises, Inc. is partially owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.